News
Last week, Protavio had the privilege of attending the Olink User Group Meeting 2024, held in Barcelona, where Olink experts gathered to share insights...
Protavio recently had the opportunity to present at the Olink Proteomics World virtual conference on September 26th, where we unveiled our cutting-edge work in...
Protavio is pleased to announce our participation in the 8th Network Meeting for Users of Multiplex Immune Assays held in Copenhagen, Denmark. Our co-founder,...
It was a great honor to have the story of Protavio presented at the Rectors’ Meeting held at the University of Patras in July....
Last week, the 1st Greek Forum on Cancer, organized by the Hellenic Cancer Federation | ELLOK, provided a holistic view of our battle with...
Protavio is thrilled to be participating as an exhibitor at the EPHAR2024 conference organized by The Federation of European Pharmacological Societies in Athens, Greece!...
Protavio has finished the latest GMP production of the custom Luminex serological assays for vaccine assessment and Quality Control (QC). These Luminex® Serological Assays...
We’re excited to announce the latest addition to the Protavio family of xMAP instruments: the Luminex xMAP INTELLIFLEX DR-SE System. With this acquisition, our...
We are excited to announce the successful completion of our latest GMP production for the 13-Plex Pneumococcal IgG Serological Luminex Assay. This latest milestone...
Protavio Ltd is thrilled to announce the winner of our highly anticipated Olink Proteomics Sample Testing Contest. This unique contest was designed to celebrate...
Protavio is proud to announce its successful participation as a sponsor at the prestigious Biomarkers UK event, held in London this February. The event,...